1207818259

The CON/ID-19 Disease Progression Monitor delivers evidence on the effects of the disease on services, systems and therapies across the Life Sciences and Healthcare sectors

Across Europę, governments and health systems have responded differently to the COVID-19 pandemie, with disparate strategies adopted to minimise social and economic disruption while protecting public health.

Variations are appearing in the progress of the pandemie, resulting from differences in the speed of response, hospital capacity and adherence to social distancing. Each region is therefore facing unique challenges in effectively managing the crisis, within the context of its own discrete public health system and socio-political context. In tum, the true progress of the pandemie and its likely evolution are still relatively unclear.

L.E.K. Consulting update

In light of new data surrounding the impact of COVID-19 on the population, health services, pharmaceutical industry and wider economy, L.E.K.'s Healthcare team is releasing regular updates on the rapidly evolving landscape.

These updates are dynamie, focusing on disease progression as measured by the responses of services, systems and therapies to the coronavirus pandemie, and accompanied by independent analysis to provide an objective view of developments observed within the Healthcare and Life Sciences industries.